The average one-year price target for Maze Therapeutics (NasdaqGM:MAZE) has been revised to $44.12 / share. This is an increase of 11.37% from the prior estimate of $39.61 dated November 14, 2025. The ...

AI legal and ethical concerns are growing as the technology rapidly advances, challenging our legal systems and societal ...

Photography, including works by Irving Penn and Sam Penn, had a great 2025 at museums, galleries, auctions, fairs, and on ...

President Donald Trump’s executive order limiting states’ ability to write their own AI regulations has caused a new wave of uncertainty.

Google CEO Sundar Pichai has issued a stark warning that the United States could lose the global artificial intelligence race ...

Netflix House Dallas blends the city’s rich culture, local talent and iconic streaming stories into an immersive entertainment experience like no other in the city.

There’s an endless amount of curious and fascinating knowledge out there in the world, and discovering it is part of what ...

Artificial intelligence (AI) has been the dominant investment trend over the past few years, and exchange-traded funds (ETFs) ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Khadija Khartit is a strategy, investment, and funding expert, and an educator of fintech and strategic finance in top universities. She has been an investor, entrepreneur, and advisor for more than ...